Annolyse
BriefingsCompaniesInsightsPrinciplesCompareChatWatchlist

Explore

  • Briefings
  • Companies
  • Insights
  • Compare

Resources

  • Search
  • Methodology

© 2026 Annolyse.

Compare covered companies

BLIS Technologies (BLT)Fisher & Paykel Healthcare (FPH)Green Cross Health (GXH)

Showing 3 companies.

← Swipe to view more
Company comparison table
MetricBLT · FY26FPH · FY26GXH · FY26
Revenue$14.7m$2.3b$546m
Revenue growth %

Get updates for BLT vs FPH vs GXH

Get new briefings that refresh this comparison when covered companies publish.

16.0%Outside range highOutside range high revenue growth. 16%; 3-period range 9.7% to 14.2%. Revenue growth: 16.0%, above normal range; 3-period mean 12.2%, range 9.7%-14.2%.
14.2%
4.2%
EBITDA—$636.4m$45.3m
EBITDA margin %—27.6%8.3%
PBT$0.8m$631.5m$35.8m
PBT growth %-11.1%Outside range lowOutside range low pbt growth. -11.1%; 3-period range 28.6% to 151.6%. PBT growth: -11.1%, below normal range; 3-period mean 76.8%, range 28.6%-151.6%.25.5%24.3%
NPAT$0.7m$468.5m$20.4m
NPAT growth %-12.5%Outside range lowOutside range low npat growth. -12.5%; 3-period range 33.3% to 147.9%. NPAT growth: -12.5%, below normal range; 3-period mean 77.1%, range 33.3%-147.9%.24.2%27.5%
Operating cash flow-$0.6m$663.2m$54.6m
OCF / EBITDA %—104.2%120.7%
FCF pre-lease-$1.1m$468m$45m
FCF post-lease—$446.6m—
DPS—52.0c5.5c
Payout ratio vs NPAT %—65.2%40.5%

Source: latest published result for each selected company.

BLT vs FPH vs GXH comparison

Copy, export, or share this public comparison table.